The chance of surviving a brain tumor is mostly determined by the type of cancer with which a patient has been diagnosed. Some kinds of brain cancer, such as meningioma, ependymoma, and oligodendroglioma, are quite curable, although others may be less so.
While cancer type is one of the most important determinants in predicting overall survival rates, other factors also play a role. Patients diagnosed with lower-grade tumors frequently have better outcomes than patients diagnosed with higher-grade malignancies. Patients diagnosed with lower-grade tumors often have better outcomes than patients diagnosed with higher-grade malignancies. We adopt a tailored approach to brain tumor therapy at Moffitt Cancer Center, offering patients a wide range of evidence-based medicines that a team of experts will recommend for their specific condition. More significantly, we consider our patients to be more than numbers. Our brain cancer team works relentlessly to ensure that our patients have access to the most effective medicines while maintaining the highest possible quality of life.